What is the recommended pediatric dosage of cephalexin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cephalexin Pediatric Dose

The recommended pediatric dosage of cephalexin is 25-50 mg/kg/day divided into 3-4 doses, with higher doses (75-100 mg/kg/day in 4 divided doses) required for otitis media. 1

Standard Dosing by Indication

General Infections (Skin, Soft Tissue, Pharyngitis)

  • Standard dose: 25-50 mg/kg/day divided every 6 hours (QID) or every 12 hours (BID) 1
  • For streptococcal pharyngitis and skin/soft tissue infections in children >1 year, the total daily dose may be divided and given every 12 hours 1

Otitis Media

  • Higher dose required: 75-100 mg/kg/day in 4 divided doses 1, 2
  • This higher dosing is specifically validated in clinical studies for adequate middle ear penetration 2

Severe Infections

  • Double the standard dose when treating severe infections 1

Context-Specific Dosing from Guidelines

Methicillin-Susceptible Staphylococcus aureus (MSSA)

For oral step-down therapy or mild MSSA infections (including pneumonia):

  • 75-100 mg/kg/day divided into 3 or 4 doses 3, 4, 3, 4
  • This is the preferred oral agent for MSSA in pediatric patients 5

Alternative Dosing Frequencies

Recent pharmacokinetic studies support less frequent dosing to improve adherence:

Three Times Daily (TID) Dosing

  • 45 mg/kg/dose (maximum 1.5 g) three times daily achieves appropriate pharmacodynamic targets 6, 7
  • This regimen showed 99% cure rate in bone and joint infections with good tolerability 6
  • For MSSA with MIC ≤2 mg/L: 15-25 mg/kg TID; for MIC 4 mg/L: 45 mg/kg TID 7

Twice Daily (BID) Dosing

  • For MSSA with MIC 1-2 mg/L: 22-45 mg/kg BID 7
  • For MSSA with MIC 4 mg/L: 80 mg/kg BID 7
  • Note: BID dosing requires higher per-dose amounts and may not be optimal for all infections

Practical Dosing Table (from FDA Label)

Weight 125 mg/5 mL QID 250 mg/5 mL QID
10 kg (22 lb) ½-1 tsp ¼-½ tsp
20 kg (44 lb) 1-2 tsp ½-1 tsp
40 kg (88 lb) 2-4 tsp 1-2 tsp

1

Important Caveats

  • Duration for streptococcal infections: Administer for at least 10 days to prevent rheumatic fever 1
  • Suspension stability: After reconstitution, refrigerate and use within 14 days 1
  • Maximum daily dose: If >4 g/day is required, consider parenteral cephalosporins 1
  • Tolerability: Higher doses (45 mg/kg TID) are generally well-tolerated, though mild neutropenia and GI symptoms can occur 6

Clinical Decision Algorithm

  1. Identify the infection type:

    • Otitis media → 75-100 mg/kg/day divided QID
    • MSSA skin/soft tissue or bone/joint → 75-100 mg/kg/day divided TID or QID
    • Streptococcal pharyngitis → 25-50 mg/kg/day divided BID or QID
    • Uncomplicated UTI → 25-50 mg/kg/day divided QID
  2. Consider adherence factors:

    • If adherence is a concern, use 45 mg/kg TID dosing (max 1.5 g/dose) for MSSA infections 6
    • Standard QID dosing remains appropriate when adherence is not an issue
  3. Adjust for severity:

    • Severe infections → double the standard dose 1
    • Life-threatening infections → consider parenteral therapy instead

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.